Current overview of the genetic background of atrial fibrillation: Possible therapeutic gene targets for the treatment of atrial fibrillation by Tetsushi Furukawa, MD, PhD, Yusuke Ebana, MD, PhD

Get full text

IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation by Yoshitaka Kimura, MD, Takeshi Aiba, MD, PhD, Tetsuo Sasano, MD, PhD, Tetsushi Furukawa, MD, PhD, Kengo Kusano, MD, PhD, Wataru Shimizu, MD, PhD

Get full text